Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior

@article{Gnl2001PromotionOP,
  title={Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior},
  author={F{\"u}sun F. G{\"o}n{\"u}l and Franklin J. Carter and Elina Petrova and Kannan Srinivasan},
  journal={Journal of Marketing},
  year={2001},
  volume={65},
  pages={79 - 90}
}
The authors investigate whether and how pricing and promotional activities influence prescription choice behavior using a comprehensive panel of physicians and data on competitive price and promotional activities. The authors find that physicians are characterized by fairly limited price sensitivity, detailing and samples have a mostly informative effect on physicians, and physicians with a relatively large number of Medicare or health maintenance organization patients are less influenced by… 

Tables from this paper

Effects of Physician‐directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence

Estimates suggest that detailing has a significant and positive effect on the number of new scripts written for the detailed drug, with an elasticity magnitude of 0.06, suggesting that most of the observed relationship between physician-directed promotion and drug sales is driven by selection bias.

The Effect of Prescription Drug Advertising on Doctor Visits

It is found that higher DTCA expenditures are associated with increased doctor visits, especially after the Food and Drug Administration clarified D TCA rules in August 1997, and the market-expanding effect is similar across demographic groups.

How Do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs

This study proposes a stylized model of pharmaceutical payments and investigates the impact of Mandatory Access Prescription Drug Monitoring Programs on opioid-specific commercial promotion directed at physicians, finding that MPDMPs reduce promotion on both extensive and intensive margins.

Information technology and agency in physicians' prescribing decisions

It is found that when given formulary IT, physicians' prescribing decisions are influenced by formularies far more than by pharmaceutical firms' detailing and sampling; without IT, formulies' effects are much smaller.

Direct to Consumer Advertising and Prescription Choice

This paper examines the effect of direct-to-consumer advertising (DTCA) of prescription drugs on doctors' choice of drug brands. Using antihistamines as an example, we show that DTCA has little

The Debate on Influencing Doctors’ Decisions: Are Drug Characteristics the Missing Link?

Decision making by physicians on patients' treatment has come under increased public scrutiny. In fact, there is a fair amount of debate on the effects of marketing actions of pharmaceutical firms

Asymmetric Responsiveness of Physician Prescription Behavior to Drug Promotion of Competitive Brands Within an Established Therapeutic Drug Class

The findings reveal that even though on average the marketing efforts affect the brand share positively, the magnitude of the effects is very brand specific.

Estimation of Promotional Strategies for Newer vs. Older Drugs Based On Physician Prescribing Data

Results from a comprehensive analysis of a physician-prescribing model draw guidelines on how to promote a new drug in the presence of competing older drugs, in a chronic therapeutic state to have novel implications for drug manufacturers on the effect of time-in-the-market.

Persistence in prescriptions of branded drugs

Effects of Drug Pricing on Medication Choice

An attempt has been made in this article to analyze the Physicians’ preferences for drug pricing, particularly for drugs prescribed in chronic ailments, and provides an outcome of physicians’ perception about higher- and lower-priced drugs.
...

References

SHOWING 1-10 OF 23 REFERENCES

What kind of patients and physicians value direct-to-consumer advertising of prescription drugs

It is found that consumers who have an ongoing need for health care, that is, those with children or with a chronic condition requiring medication, value prescription drug advertising more highly, while older consumers, consumers who has been sick recently, or more educated consumers are more likely to trust their physicians instead.

The Demand for Post-Patent Prescription Pharmaceuticals

Patients who are treated by physicians with large numbers of HMO or pre-paid patients are more likely to be prescribed generics, and there is wide regional variation in the propensity of physicians to prescribe generic drugs.

Persuasion or Information? The Economics of Prescription Drug Advertising

  • K. Leffler
  • Economics, Business
    The Journal of Law and Economics
  • 1981
THE economic and welfare effects of advertising have been extensively studied over the last half-century. However, these efforts have not led to a consensus either as to the effects or the value of

The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry

The introduction of Tagamet in the United States in 1977 represented both a revolution in ulcer therapy and the beginning of an important new industry. Today there are four prescription H2-

Managed care plan performance since 1980. A literature analysis.

The evidence does not support the hypothesis that prepaid group practice or staff model health Maintenance organizations are more effective than individual practice association or network model health maintenance organizations.

The accuracy of drug information from pharmaceutical sales representatives.

Eleven percent of the statements made by pharmaceutical representatives about drugs contradicted information readily available to physicians, and Physicians generally failed to recognize the inaccurate statements.

Free for All?: Lessons from the RAND Health Insurance Experiment

In the most important health insurance study ever conducted researchers at the RAND Corporation devised all experiment to address two key questions in health care financing: how much more medical

Prescription Drug Advertising: An Industry Perspective

The Upjohn Company is an advertiser and takes the responsibility of advertising their products very seriously and is proud of the quality products the authors advertise, and proud that these products benefit millions of people in more than 150 countries worldwide.

Toward a Reconciliation of Market Power and Information Theories of Advertising Effects on Price Elasticity

Prior work on the economic effects of advertising has presented conflicting views. Some authors have suggested that advertising creates market power by artificially differentiating brands and thereby

An Advocacy Behavior Model of Organizational Buyers’ Vendor Choice

Ability to influence members of organizational buying groups is often the chief requirement for a successful industrial marketing effort. One approach is to stimulate a buying center boundary role